Literature DB >> 3694267

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

S Markowitz1, K Saito, M A Moskowitz.   

Abstract

Utilizing 125I-BSA administered intravenously, a simple, reliable, and sensitive method was established for the detection of plasma protein extravasation in the dura of rats and guinea pigs following chemical, electrical, or immunological stimulation. Extravasated 125I-BSA or Evans blue was noted in the dura and conjunctiva but not in the temporalis muscle of saline-perfused rats following intravenous capsaicin, 1 mumol/kg. Capsaicin-induced extravasation was mediated by unmyelinated and small myelinated fibers since leakage did not develop in adult animals in whom these fibers were destroyed by capsaicin pretreatment (50 mg/kg) as neonates. An ipsilateral increase in Evans blue and 125I-BSA was found in the dura, eyelids, lips and gingival mucosa, and snout following electrical stimulation of the rat trigeminal ganglion. This increase was also C-fiber dependent. Among those peptides contained in perivascular afferent fibers and administered intravenously, substance P (SP) and neurokinin A (NKA), but not calcitonin gene-related peptide, caused a dose-dependent extravasation in the dura and conjunctiva of rats. Neonatal capsaicin pretreatment did not attenuate SP- nor NKA-induced effects in the dura and actually increased extravasation in the conjunctiva. Intravenous administration of 5-HT or bradykinin to normal adult rats or adult rats pretreated as neonates with capsaicin increased levels of 125I-BSA in both the dura and the conjunctiva. Histamine and prostaglandin E2, on the other hand, caused protein leakage in the conjunctiva but not in the dura of rats; however, histamine did induce extravasation in the dura of guinea pigs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694267      PMCID: PMC6569119     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  97 in total

1.  Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals.

Authors:  A Sams-Nielsen; C Orskov; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  [PET and Doppler sonography in headaches].

Authors:  A May; C Weiller
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

Review 3.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

4.  Choroidal thickness measurements in migraine patients during attack-free period.

Authors:  Emine Esra Karaca; Emine Belgin Koçer; Şengül Özdek; Hanife Tuba Akçam; Merve Bahar Ercan
Journal:  Neurol Sci       Date:  2015-08-15       Impact factor: 3.307

Review 5.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.

Authors:  T Matsubara; M A Moskowitz; B Byun
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

Review 8.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 9.  Molecular mechanisms of migraine?

Authors:  S V Ramagopalan; N E Ramscar; M Z Cader
Journal:  J Neurol       Date:  2007-11-07       Impact factor: 4.849

10.  Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.

Authors:  Zdravko Lacković; Boris Filipović; Ivica Matak; Zsuzsanna Helyes
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.